1. Home
  2. CALY vs PBLS Comparison

CALY vs PBLS Comparison

Compare CALY & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CALY

Callaway Golf Company

N/A

Current Price

$18.36

Market Cap

3.0B

Sector

N/A

ML Signal

N/A

Logo Parabilis Medicines Inc. Common Stock

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$30.81

Market Cap

3.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CALY
PBLS
Founded
1982
N/A
Country
United States
United States
Employees
28000
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.6B
IPO Year
N/A
2026

Fundamental Metrics

Financial Performance
Metric
CALY
PBLS
Price
$18.36
$30.81
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$16.50
N/A
AVG Volume (30 Days)
2.2M
545.1K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.70
N/A
Revenue Next Year
$3.01
N/A
P/E Ratio
$64.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.26
$25.56
52 Week High
$20.28
$33.65

Technical Indicators

Market Signals
Indicator
CALY
PBLS
Relative Strength Index (RSI) 52.02 58.33
Support Level $17.74 $26.83
Resistance Level $19.36 $30.90
Average True Range (ATR) 0.60 2.46
MACD -0.13 -0.02
Stochastic Oscillator 23.43 61.83

Price Performance

Historical Comparison
CALY
PBLS

About CALY Callaway Golf Company

Callaway Golf Co is a golf equipment, gear and apparel company with a portfolio of world-wide brands, including Callaway Golf, Odyssey, TravisMathew, and OGIO. Callaway designs, manufactures, and sells high-performance golf clubs, golf balls, apparel, bags, and other accessories-setting the standard for performance in the game of golf. The company has two operating and reportable business segments: Golf Equipment and Apparel, Gear and Other. Geographically, the company operates in United States, Europe, Asia, and Rest of World, of which it derives maximum revenue from United States.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: